These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8757318)

  • 1. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective T cells from gld mice play a pivotal role in development of Thy-1.2+B220+ cells and autoimmunity.
    Yasutomo K; Maeda K; Nagata S; Nagasawa H; Okada K; Good RA; Kuroda Y; Himeno K
    J Immunol; 1994 Dec; 153(12):5855-64. PubMed ID: 7527451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
    Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
    J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
    Booker JK; Reap EA; Cohen PL
    J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of grafted gld cells in athymic and euthymic recipients.
    Rosenblatt N; Hartmann KU; Loor F
    Immunology; 1995 Apr; 84(4):562-70. PubMed ID: 7790030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
    Jenkins M; Keir M; McCune JM
    J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
    Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
    Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of allograft tolerance in the absence of Fas-mediated apoptosis.
    Li XC; Li Y; Dodge I; Wells AD; Zheng XX; Turka LA; Strom TB
    J Immunol; 1999 Sep; 163(5):2500-7. PubMed ID: 10452986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fas-deficient SCID mouse exhibits the development of T cells in the thymus.
    Yasutomo K; Maeda K; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1997 May; 158(10):4729-33. PubMed ID: 9144486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
    Tamura A; Katsumata M; Greene MI; Yui K
    Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
    Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
    J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas/Fas ligand signaling during gestational T cell development.
    Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
    J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.